Gli1 appears to be constitutively expressed in the lumenal epithelial cells of the prostate but not in the basal cell layer or the mesenchyme od Spencer, A, Bury, J, Feeley, K, Azzouzi, A, Hamdy, F, Cross, S

Loss of intercellular expression of beta-dystroglycan is a common event in prostate cancer and is significantly associated with loss of differentiation od Cross, S, Hollingbury, F, Lippitt, J, Feeley, K, Azzouzi, A, Winder, S, Hamdy, F

Artificial intelligence in predicting bladder cancer outcome: a comparison of neuro-fuzzy modeling and artificial neural networks. od Catto, J, Linkens, D, Abbod, M, Chen, M, Burton, J, Feeley, K, Hamdy, F

Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study. od Rehman, I, Azzouzi, A, Catto, J, Allen, S, Cross, S, Feeley, K, Meuth, M, Hamdy, F

Proteomic analysis of voided urine following prostatic massage reveals tumour specific alterations od Rehman, I, Azzouzi, A, Catto, J, Allen, S, Cross, S, Feeley, K, Eaton, C, Meuth, M, Hamdy, F

Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma. od Dhawan, D, Hamdy, F, Rehman, I, Patterson, J, Cross, S, Feeley, K, Stephenson, Y, Meuth, M, Catto, J

Proteomics and immunohistochemistry identify loss of nucleophosmin (B23) expression in bladder transitional cell carcinomas od Ahmad, M, Catto, J, Azzouzi, A, Cross, S, Feeley, K, Eaton, C, Meuth, M, Hamdy, F, Rehman, I

Clinically localised prostate cancer is microsatellite stable. od Azzouzi, A, Catto, J, Rehman, I, Larre, S, Roupret, M, Feeley, K, Cussenot, O, Meuth, M, Hamdy, F

Calgizzarin (S100A11) immunostaining pattern is altered in prostate cancer suggesting a role in tumourigenesis od Rehman, I, Azzouzi, A, Catto, J, Ahmad, M, Deloulme, U, Cross, S, Feeley, K, Eaton, C, Meuth, M, Hamdy, F

Distinct patterns of microsatellite instability are seen in tumours of the urinary tract. od Catto, J, Azzouzi, A, Amira, N, Rehman, I, Feeley, K, Cross, S, Fromont, G, Sibony, M, Hamdy, F, Cussenot, O, Meuth, M

Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma. od Catto, J, Azzouzi, A, Rehman, I, Feeley, K, Cross, S, Amira, N, Fromont, G, Sibony, M, Cussenot, O, Meuth, M, Hamdy, F